Falvella FS - Search Results

1

MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment.

Spinola M, Falvella FS, Colombo F, Sullivan JP, Shames DS, Girard L, Spessotto P, Minna JD, Dragani TA. Spinola M, et al. Among authors: falvella fs. Mol Cancer. 2010 Mar 17;9:62. doi: 10.1186/1476-4598-9-62. Mol Cancer. 2010. PMID: 20236515 Free PMC article.

2

FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.

Falvella FS, Frullanti E, Galvan A, Spinola M, Noci S, De Cecco L, Nosotti M, Santambrogio L, Incarbone M, Alloisio M, Calabrò E, Pastorino U, Skaug V, Haugen A, Taioli E, Dragani TA. Falvella FS, et al. Int J Cancer. 2009 Jun 15;124(12):2880-5. doi: 10.1002/ijc.24302. Int J Cancer. 2009. PMID: 19296538

3

A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.

Colombo F, Falvella FS, Galvan A, Frullanti E, Kunitoh H, Ushijima T, Dragani TA. Colombo F, et al. Among authors: falvella fs. Mol Cancer. 2011 Jul 7;10:81. doi: 10.1186/1476-4598-10-81. Mol Cancer. 2011. PMID: 21736709 Free PMC article.

4

Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue.

Frullanti E, Colombo F, Falvella FS, Galvan A, Noci S, De Cecco L, Incarbone M, Alloisio M, Santambrogio L, Nosotti M, Tosi D, Pastorino U, Dragani TA. Frullanti E, et al. Among authors: falvella fs. Int J Cancer. 2012 Sep 1;131(5):E643-8. doi: 10.1002/ijc.27426. Epub 2012 Feb 28. Int J Cancer. 2012. PMID: 22223368

5

Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival.

Spinola M, Falvella FS, Galvan A, Pignatiello C, Leoni VP, Pastorino U, Paroni R, Chen S, Skaug V, Haugen A, Dragani TA. Spinola M, et al. Among authors: falvella fs. Lung Cancer. 2007 Mar;55(3):271-7. doi: 10.1016/j.lungcan.2006.10.023. Epub 2006 Dec 4. Lung Cancer. 2007. PMID: 17145094 Free article.

6

N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers.

Spinola M, Colombo F, Falvella FS, Dragani TA. Spinola M, et al. Among authors: falvella fs. Int J Cancer. 2007 Jun 15;120(12):2744-8. doi: 10.1002/ijc.22601. Int J Cancer. 2007. PMID: 17304507

7

Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine.

Colombo F, Falvella FS, De Cecco L, Tortoreto M, Pratesi G, Ciuffreda P, Ottria R, Santaniello E, Cicatiello L, Weisz A, Dragani TA. Colombo F, et al. Among authors: falvella fs. Int J Cancer. 2009 May 1;124(9):2179-85. doi: 10.1002/ijc.24168. Int J Cancer. 2009. PMID: 19123479

8

Identification of RASSF8 as a candidate lung tumor suppressor gene.

Falvella FS, Manenti G, Spinola M, Pignatiello C, Conti B, Pastorino U, Dragani TA. Falvella FS, et al. Oncogene. 2006 Jun 29;25(28):3934-8. doi: 10.1038/sj.onc.1209422. Epub 2006 Feb 6. Oncogene. 2006. PMID: 16462760

9

BHLHB3: a candidate tumor suppressor in lung cancer.

Falvella FS, Colombo F, Spinola M, Campiglio M, Pastorino U, Dragani TA. Falvella FS, et al. Oncogene. 2008 Jun 12;27(26):3761-4. doi: 10.1038/sj.onc.1211038. Epub 2008 Jan 28. Oncogene. 2008. PMID: 18223678

10

A polygenic model with common variants may predict lung adenocarcinoma risk in humans.

Galvan A, Falvella FS, Spinola M, Frullanti E, Leoni VP, Noci S, Alonso MR, Zolin A, Spada E, Milani S, Pastorino U, Incarbone M, Santambrogio L, Gonzalez Neira A, Dragani TA. Galvan A, et al. Among authors: falvella fs. Int J Cancer. 2008 Nov 15;123(10):2327-30. doi: 10.1002/ijc.23789. Int J Cancer. 2008. PMID: 18729187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters